Newsroom
Sorted by: Latest
-
NATIXIS UK Regulatory Announcement: Form 8.3 - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) AMENDED – This disclosure replaces the one published on February 16, 2026 08:06 AM Eastern Standard Time – Ticker has been updated for linking purposes. 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different...
-
NATIXIS UK Regulatory Announcement: Form 8.3 - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) AMENDED – This disclosure replaces the one published on February 10, 2026 07:59 AM Eastern Standard Time – Ticker has been updated for linking purposes. 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different...
-
Ladder Capital Corp Announces First Quarter 2026 Dividend to Holders of Class A Common Stock
NEW YORK--(BUSINESS WIRE)--Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) today announced the declaration by its board of directors of a first quarter 2026 dividend of $0.23 per share of Class A common stock. The cash dividend is payable on April 15, 2026 to stockholders of record as of the close of business on March 31, 2026. About Ladder Ladder is a publicly listed, investment grade-rated commercial real estate finance company with a diversified, nationwide platform. We deliver...
-
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics, LLC (“Ignite”), a commercial-stage precision oncology company focused on addressing a critical challenge in cancer care: optimizing therapy selection. Ignite’s functional proteomics platform has demonstrated the ability to identify cancer therapy responses that may not be cap...
-
Amsterdam & Partners LLP Publishes Open Letter Demanding Full Transparency From Spain's AEAT
MADRID & LONDON & WASHINGTON--(BUSINESS WIRE)--Amsterdam & Partners LLP, the international law and political advocacy firm, today published an open letter addressed to Soledad Fernández Doctor, Director General of Spain's Agencia Estatal de Administración Tributaria (AEAT), accusing the agency of operating a predatory bonus system that incentivises its inspectors to extract ever-greater sums from Spanish taxpayers and foreign residents alike, while publicly misrepresenting the scale and nat...
-
NATIXIS UK Regulatory Announcement: Form 8.3 - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) AMENDED – This disclosure replaces the one published on February 12, 2026 05:50 AM Eastern Standard Time – Ticker has been updated for linking purposes. 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different...
-
Hello, Cincinnati: CAVA’s Expansion Into the Midwest Continues
WASHINGTON--(BUSINESS WIRE)--CAVA (NYSE: CAVA), the category-defining Mediterranean fast-casual restaurant brand, opened its doors today at 3356 Madison Road in Cincinnati, Ohio. CAVA Oakley Station is a 3,200-square-foot location with a bright dining room, convenient digital order pick-up, and delivery options designed to meet guests where they are depending on the day - bringing bold, craveable Mediterranean flavors that will leave Cincinnati guests feeling energized, satisfied, and well nour...
-
NATIXIS UK Regulatory Announcement: Form 8.3 - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) AMENDED – This disclosure replaces the one published on February 13, 2026 05:33 AM Eastern Standard Time – Ticker has been updated for linking purposes. 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different...
-
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of a new national survey conducted on its behalf by The Harris Poll with findings demonstrating that more than 9 out of 10 Americans ages 45 and over believe in ensuring broader coverage for blood-based colorectal cancer (CRC) screening, including new innovations like Shield™ by Guardant, a methylation partitioning cell-free DNA (mp-cfDNA) test and the first...
-
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and full year 2025 on Thursday, March 26, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter...